These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 503619)

  • 1. An in vitro quantitative systems pharmacology approach for deconvolving mechanisms of drug-induced, multilineage cytopenias.
    Wilson JL; Lu D; Corr N; Fullerton A; Lu J
    PLoS Comput Biol; 2020 Jul; 16(7):e1007620. PubMed ID: 32701980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds].
    Kholodnyi MD; Mindlin SS
    Vopr Onkol; 1969; 15(8):27-32. PubMed ID: 4982329
    [No Abstract]   [Full Text] [Related]  

  • 3. [On hematopoietic changesin patients with malignant ovarian tumors during chemotherapy].
    Turbina IL; Mezentseva SK
    Vopr Onkol; 1965; 11(8):38-41. PubMed ID: 4957708
    [No Abstract]   [Full Text] [Related]  

  • 4. [The hemoprotective effect of Dicarbamin in ovarian cancer patients receiving chemotherapy].
    Raĭkhlin NT; Gorbunova VA; Treshchalina EM; Bychkov MB; Smirnova EA; Mindra NV; Topchieva SV; Zubrikhina GN; Nebol'sin VE
    Vopr Onkol; 2004; 50(2):188-95. PubMed ID: 15176222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of hemopoiesis due to cytostatic therapy and its treatment (author's transl)].
    Klener P; Donner L; Smotlachová I
    Cas Lek Cesk; 1977 Feb; 116(4):117-9. PubMed ID: 844069
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention and treatment of hemopoietic disorders during the chemotherapy of malignant ovarian tumors].
    Rybalka AM
    Pediatr Akus Ginekol; 1979; (5):45-6. PubMed ID: 503619
    [No Abstract]   [Full Text] [Related]  

  • 7. [Present state and perspectives concerning the medical treatment of cancer].
    Vermel' EM
    Vopr Onkol; 1969; 15(1):92-104. PubMed ID: 4185056
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reduction in hematotoxicity of chemotherapy using reinfusion of hematopoietic stem cells].
    van Hoef ME
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):240-4. PubMed ID: 8094541
    [No Abstract]   [Full Text] [Related]  

  • 9. Current role of chemotherapy protectors in cancer treatment.
    Cáceres W; Báez L; Aponte I; Rodríguez N; Maldonado A
    Bol Asoc Med P R; 1997; 89(10-12):184-8. PubMed ID: 9577052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of malignant tumors].
    Witte S
    Internist (Berl); 1968 Sep; 9(9):365-75. PubMed ID: 4918656
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraperitoneal chemotherapy for women with epithelial ovarian cancer.
    Trimble EL; Thompson S; Christian MC; Minasian L
    Oncologist; 2008 Apr; 13(4):403-9. PubMed ID: 18448554
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.